← Back to Search

Patient Portal Intervention for Type 2 Diabetes

N/A
Waitlist Available
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights

Summary

This trial will develop and test a multi-level intervention to get patients with diabetes to use electronic portals to manage their health.

Who is the study for?
This trial is for adults over 18 with Type 2 Diabetes (T2D) who have been patients at partner community health centers, can read English or Spanish, and are not currently using the patient portal. They must have had T2D for more than six months and an A1c level above 7.5%. People with gestational diabetes or cognitive impairment that affects their ability to participate in the study cannot join.
What is being tested?
The study is testing a program designed to help people with Type 2 Diabetes use a patient portal more effectively as part of managing their condition. The intervention includes various strategies implemented at different levels within community health centers.
What are the potential side effects?
Since this trial involves educational interventions rather than medications, traditional side effects are not expected. However, participants may experience challenges such as frustration or confusion when learning new technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in A1C value
Usage of Portal
Secondary study objectives
Diabetes Self-Efficacy
Health Care Climate Questionnaire
Health care engagement - negative
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Use of patient portal for diabetes managementExperimental Treatment1 Intervention
A multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,765 Previous Clinical Trials
8,133,485 Total Patients Enrolled
Yale UniversityLead Sponsor
1,907 Previous Clinical Trials
3,019,023 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
417 Previous Clinical Trials
1,370,823 Total Patients Enrolled

Media Library

Use of patient portal for diabetes management Clinical Trial Eligibility Overview. Trial Name: NCT05180721 — N/A
Type 2 Diabetes Research Study Groups: Use of patient portal for diabetes management
Type 2 Diabetes Clinical Trial 2023: Use of patient portal for diabetes management Highlights & Side Effects. Trial Name: NCT05180721 — N/A
Use of patient portal for diabetes management 2023 Treatment Timeline for Medical Study. Trial Name: NCT05180721 — N/A
~0 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top